{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:11:25Z","timestamp":1785179485488,"version":"3.55.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 72661"],"award-info":[{"award-number":["grant number: 72661"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04349-1","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:40:27Z","timestamp":1760524827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum markers and gastric cancer: an umbrella review"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0584-8750","authenticated-orcid":false,"given":"Afra","family":"Darvishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7020-1864","authenticated-orcid":false,"given":"Amirhosein","family":"Dadashzadeh Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5682-4785","authenticated-orcid":false,"given":"Pouya","family":"Golshaniniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4752-0394","authenticated-orcid":false,"given":"Ali","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-0109","authenticated-orcid":false,"given":"Amirreza","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4885","authenticated-orcid":false,"given":"Sina","family":"Hamzehzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-2106","authenticated-orcid":false,"given":"Hanieh","family":"Salehi-Pourmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"4349_CR1","doi-asserted-by":"publisher","unstructured":"Hou W, Zhao Y, Zhu H. Predictive biomarkers for immunotherapy in gastric cancer: current status and emerging prospects. Int J Mol Sci. 2023;24(20):15321. https:\/\/doi.org\/10.3390\/ijms242015321.","DOI":"10.3390\/ijms242015321"},{"issue":"9","key":"4349_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s10038-021-00960-8","volume":"66","author":"H Katoh","year":"2021","unstructured":"Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in East Asian populations. J Hum Genet. 2021;66(9):887\u201399.","journal-title":"J Hum Genet"},{"issue":"1","key":"4349_CR3","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1038\/s41598-025-90064-6","volume":"15","author":"SE Mousavi","year":"2025","unstructured":"Mousavi SE, Ilaghi M, Elahi Vahed I, Nejadghaderi SA. Epidemiology and socioeconomic correlates of gastric cancer in asia: results from the GLOBOCAN 2020 data and projections from 2020 to 2040. Sci Rep. 2025;15(1):6529.","journal-title":"Sci Rep"},{"issue":"8","key":"4349_CR4","first-page":"e28602","volume":"14","author":"S Kommuru","year":"2022","unstructured":"Kommuru S, Ibrahim Y, Ashara YP, Singh K, Shah MP, Shah SD, et al. Sex differences in All-Cause inpatient mortality risk in gastric cancer: nationwide inpatient Population-Based study. Cureus. 2022;14(8):e28602.","journal-title":"Cureus"},{"issue":"7","key":"4349_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3109\/0284186X.2012.673732","volume":"51","author":"E Hiripi","year":"2012","unstructured":"Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, et al. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. 2012;51(7):906\u201314.","journal-title":"Acta Oncol"},{"issue":"10251","key":"4349_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"2","key":"4349_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.15171\/jarcm.2017.011","volume":"5","author":"B Gholizade","year":"2017","unstructured":"Gholizade B, Malekpour N. Effective factors on 3-year mortality of operated gastric cancer at modarres hospital during 5 years. J Anal Res Clin Med. 2017;5(2):58\u201361.","journal-title":"J Anal Res Clin Med"},{"issue":"1","key":"4349_CR8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1186\/s12885-024-13141-5","volume":"24","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang W, Tan X, He W, Zhao L, Liu H, et al. Long-term relative survival of patients with gastric cancer from a large-scale cohort: a period-analysis. BMC Cancer. 2024;24(1):1420.","journal-title":"BMC Cancer"},{"issue":"5","key":"4349_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.27711","volume":"132","author":"F Bray","year":"2013","unstructured":"Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133\u201345.","journal-title":"Int J Cancer"},{"issue":"3","key":"4349_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.34172\/mejdd.2022.292","volume":"14","author":"M Ghojazadeh","year":"2022","unstructured":"Ghojazadeh M, Somi MH, Naseri A, Salehi-Pourmehr H, Hassannezhad S, Hajikamanaj Olia A, et al. Systematic review and Meta-analysis of TP53, HER2\/ERBB2, KRAS, APC, and PIK3CA genes expression pattern in gastric cancer. Middle East J Dig Dis. 2022;14(3):335\u201345.","journal-title":"Middle East J Dig Dis"},{"issue":"4","key":"4349_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jjco\/hyn017","volume":"38","author":"C Hamashima","year":"2008","unstructured":"Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38(4):259\u201367.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"4349_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(08)70072-X","volume":"9","author":"WK Leung","year":"2008","unstructured":"Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in asia: current evidence and practice. Lancet Oncol. 2008;9(3):279\u201387.","journal-title":"Lancet Oncol"},{"issue":"6","key":"4349_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bpg.2015.09.013","volume":"29","author":"K Sugano","year":"2015","unstructured":"Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):895\u2013905.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"4349_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-023-01715-z","volume":"22","author":"S Ma","year":"2023","unstructured":"Ma S, Zhou M, Xu Y, Gu X, Zou M, Abudushalamu G, et al. Clinical application and detection techniques of liquid biopsy in gastric cancer. Mol Cancer. 2023;22(1):7.","journal-title":"Mol Cancer"},{"issue":"3","key":"4349_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.gtc.2022.05.001","volume":"51","author":"DA Norwood","year":"2022","unstructured":"Norwood DA, Montalvan-Sanchez E, Dominguez RL, Morgan DR. Gastric cancer: emerging trends in Prevention, Diagnosis, and treatment. Gastroenterol Clin North Am. 2022;51(3):501\u201318.","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"4349_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ijc.26430","volume":"130","author":"CA Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130(4):745\u201353.","journal-title":"Int J Cancer"},{"issue":"26","key":"4349_CR17","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","volume":"24","author":"T Matsuoka","year":"2018","unstructured":"Matsuoka T, Yashiro M. Biomarkers of gastric cancer: current topics and future perspective. World J Gastroenterol. 2018;24(26):2818\u201332.","journal-title":"World J Gastroenterol"},{"key":"4349_CR18","doi-asserted-by":"publisher","first-page":"749250","DOI":"10.3389\/fmed.2021.749250","volume":"8","author":"M Chivu-Economescu","year":"2021","unstructured":"Chivu-Economescu M, Necula L, Matei L, Dragu D, Bleotu C, Diaconu CC. Clinical applications of liquid biopsy in gastric cancer. Front Med (Lausanne). 2021;8:749250.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"4349_CR19","doi-asserted-by":"publisher","first-page":"e10899","DOI":"10.1016\/j.heliyon.2022.e10899","volume":"8","author":"T Jiang","year":"2022","unstructured":"Jiang T, Mei L, Yang X, Sun T, Wang Z, Ji Y. Biomarkers of gastric cancer: current advancement. Heliyon. 2022;8(10):e10899.","journal-title":"Heliyon"},{"issue":"1","key":"4349_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","volume":"17","author":"H Shimada","year":"2014","unstructured":"Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the task force of the Japanese gastric cancer association. Gastric Cancer. 2014;17(1):26\u201333.","journal-title":"Gastric Cancer"},{"key":"4349_CR21","doi-asserted-by":"crossref","unstructured":"Aromataris E, Fernandez R, Godfrey C, Holly C, Khalil H, Tungpunkom P. Chapter 10: umbrella reviews. JBI manual for evidence synthesis JBI. 2020.","DOI":"10.46658\/JBIRM-17-08"},{"key":"4349_CR22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"3","key":"4349_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132\u201340.","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"4349_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1055-9965.EPI-11-0834","volume":"21","author":"MC Camargo","year":"2012","unstructured":"Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(1):20\u201338.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"4349_CR25","doi-asserted-by":"publisher","first-page":"15600","DOI":"10.18632\/oncotarget.7205","volume":"7","author":"HY Gong","year":"2016","unstructured":"Gong HY, He JG, Li BS. Meta-analysis of the association between selenium and gastric cancer risk. Oncotarget. 2016;7(13):15600\u20135.","journal-title":"Oncotarget"},{"issue":"11","key":"4349_CR26","doi-asserted-by":"publisher","first-page":"e0142080","DOI":"10.1371\/journal.pone.0142080","volume":"10","author":"YK Huang","year":"2015","unstructured":"Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X, Tian SB, et al. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: A systematic review and Meta-Analysis. PLoS ONE. 2015;10(11):e0142080.","journal-title":"PLoS ONE"},{"key":"4349_CR27","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.12659\/MSM.913375","volume":"25","author":"J Li","year":"2019","unstructured":"Li J, Lei J, He L, Fan X, Yi F, Zhang W. Evaluation and monitoring of superoxide dismutase (SOD) activity and its clinical significance in gastric cancer: A systematic review and Meta-Analysis. Med Sci Monit. 2019;25:2032\u201342.","journal-title":"Med Sci Monit"},{"key":"4349_CR28","first-page":"3115","volume":"8","author":"B Liang","year":"2015","unstructured":"Liang B, Zhong L, He Q, Wang S, Pan Z, Wang T, et al. Serum dickkopf-1 as a biomarker in screening Gastrointestinal cancers: a systematic review and meta-analysis. Onco Targets Ther. 2015;8:3115\u201322.","journal-title":"Onco Targets Ther"},{"issue":"10","key":"4349_CR29","doi-asserted-by":"publisher","first-page":"e109783","DOI":"10.1371\/journal.pone.0109783","volume":"9","author":"T Terasawa","year":"2014","unstructured":"Terasawa T, Nishida H, Kato K, Miyashiro I, Yoshikawa T, Takaku R, et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern asians: a systematic review and meta-analysis. PLoS ONE. 2014;9(10):e109783.","journal-title":"PLoS ONE"},{"issue":"30","key":"4349_CR30","doi-asserted-by":"publisher","first-page":"48671","DOI":"10.18632\/oncotarget.8932","volume":"7","author":"T Wei","year":"2016","unstructured":"Wei T, Ye P, Peng X, Wu LL, Yu GY. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies. Oncotarget. 2016;7(30):48671\u201391.","journal-title":"Oncotarget"},{"issue":"10","key":"4349_CR31","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/ijc.28807","volume":"136","author":"S Werner","year":"2015","unstructured":"Werner S, Chen H, Tao S, Brenner H. Systematic review: serum autoantibodies in the early detection of gastric cancer. Int J Cancer. 2015;136(10):2243\u201352.","journal-title":"Int J Cancer"},{"issue":"2 Pt 1","key":"4349_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1158\/1078-0432.466.11.2","volume":"11","author":"M Ishikawa","year":"2005","unstructured":"Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11(2 Pt 1):466\u201372.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4349_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00535-009-0063-5","volume":"44","author":"TE Nakajima","year":"2009","unstructured":"Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H, et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol. 2009;44(7):685\u2013.","journal-title":"J Gastroenterol"},{"issue":"4","key":"4349_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s12032-009-9382-x","volume":"27","author":"M Seker","year":"2010","unstructured":"Seker M, Bilici A, Sonmez B, Ustaalio\u011flu BB, Gumus M, Gozu H, et al. The association of serum adiponectin levels with histopathological variables in gastric cancer patients. Med Oncol. 2010;27(4):1319\u201323.","journal-title":"Med Oncol"},{"key":"4349_CR35","doi-asserted-by":"publisher","first-page":"h1435","DOI":"10.1136\/bmj.h1435","volume":"350","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P. Meta-analyses: what is heterogeneity? BMJ. BMJ. 2015;350:h1435.","journal-title":"BMJ"},{"issue":"1","key":"4349_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-5378.2007.00475.x","volume":"12","author":"AC de Vries","year":"2007","unstructured":"de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12(1):1\u201315.","journal-title":"Helicobacter"},{"issue":"28","key":"4349_CR37","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3748\/wjg.v22.i28.6385","volume":"22","author":"C Hamashima","year":"2016","unstructured":"Hamashima C. Benefits and harms of endoscopic screening for gastric cancer. World J Gastroenterol. 2016;22(28):6385\u201392.","journal-title":"World J Gastroenterol"},{"key":"4349_CR38","doi-asserted-by":"publisher","unstructured":"Kapteijn NEA, M\u00fclder DT, Lansdorp-Vogelaar I. Cost-effectiveness of upper endoscopy for gastric cancer screening and surveillance in Western populations. Best Pract Res Clin Gastroenterol. 2025;vol75:101982. https:\/\/doi.org\/10.1016\/j.bpg.2025.101982.","DOI":"10.1016\/j.bpg.2025.101982"},{"issue":"10","key":"4349_CR39","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.7150\/jca.95311","volume":"15","author":"Y Huang","year":"2024","unstructured":"Huang Y, Shao Y, Yu X, Chen C, Guo J, Ye G. Global progress and future prospects of early gastric cancer screening. J Cancer. 2024;15(10):3045.","journal-title":"J Cancer"},{"key":"4349_CR40","first-page":"868645","volume":"2012","author":"E Lastraioli","year":"2012","unstructured":"Lastraioli E, Romoli MR, Arcangeli A. Immunohistochemical biomarkers in gastric cancer research and management. Int J Surg Oncol. 2012;2012:868645.","journal-title":"Int J Surg Oncol"},{"issue":"6","key":"4349_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/13547500600899134","volume":"11","author":"M Monari","year":"2006","unstructured":"Monari M, A. T C, C O, C P, SG JF, et al. Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers. 2006;11(6):574\u201384.","journal-title":"Biomarkers"},{"issue":"2","key":"4349_CR42","first-page":"131","volume":"54","author":"Y Dincer","year":"2007","unstructured":"Dincer Y, Himmetoglu S, Akcay T, Ersoy EY, Gunes KN, Tortum O. Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma. Neoplasma. 2007;54(2):131\u20136.","journal-title":"Neoplasma"},{"issue":"1","key":"4349_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0304-3835(03)00147-2","volume":"195","author":"SS Khanzode","year":"2003","unstructured":"Khanzode SS, Khanzode SD, Dakhale GN. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett. 2003;195(1):27\u201331.","journal-title":"Cancer Lett"},{"issue":"9","key":"4349_CR44","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/antiox12091675","volume":"12","author":"M Zheng","year":"2023","unstructured":"Zheng M, Liu Y, Zhang G, Yang Z, Xu W, Chen Q. The applications and mechanisms of superoxide dismutase in Medicine, Food, and cosmetics. Antioxidants. 2023;12(9):1675.","journal-title":"Antioxidants"},{"key":"4349_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ibneur.2023.11.007","volume":"16","author":"SB Chidambaram","year":"2024","unstructured":"Chidambaram SB, Anand N, Varma SR, Ramamurthy S, Vichitra C, Sharma A, et al. Superoxide dismutase and neurological disorders. IBRO Neurosci Rep. 2024;16:373\u201394.","journal-title":"IBRO Neurosci Rep"},{"issue":"2","key":"4349_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/antiox11020427","volume":"11","author":"J Xu","year":"2022","unstructured":"Xu J, Su X, Burley SK, Zheng XFS. Nuclear SOD1 in growth Control, oxidative stress Response, amyotrophic lateral Sclerosis, and cancer. Antioxidants. 2022;11(2):427.","journal-title":"Antioxidants"},{"issue":"4","key":"4349_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5230\/jgc.2012.12.4.217","volume":"12","author":"JH Ji","year":"2012","unstructured":"Ji JH, Shin DG, Kwon Y, Cho DH, Lee KB, Park SS, et al. Clinical correlation between gastric cancer type and serum selenium and zinc levels. J Gastric Cancer. 2012;12(4):217\u201322.","journal-title":"J Gastric Cancer"},{"issue":"1","key":"4349_CR48","doi-asserted-by":"publisher","first-page":"21378","DOI":"10.1038\/s41598-024-66553-5","volume":"14","author":"NT Le","year":"2024","unstructured":"Le NT, Pham YT-H, Le CT-K, Le LT, Le T-D, Dao HV, et al. A U-shaped association between selenium intake and cancer risk. Sci Rep. 2024;14(1):21378.","journal-title":"Sci Rep"},{"issue":"5","key":"4349_CR49","first-page":"418","volume":"51","author":"H Sjunnesson","year":"2001","unstructured":"Sjunnesson H, Stureg\u00e5rd E, Will\u00e9n R, Wadstr\u00f6m T. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the Guinea pig. Comp Med. 2001;51(5):418\u201323.","journal-title":"Comp Med"},{"issue":"1","key":"4349_CR50","first-page":"Cd005195","volume":"1","author":"M Vinceti","year":"2018","unstructured":"Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018;1(1):Cd005195.","journal-title":"Cochrane Database Syst Rev"},{"key":"4349_CR51","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3332\/ecancer.2022.1351","volume":"16","author":"K Zyambo","year":"2022","unstructured":"Zyambo K, Kelly P, Kayamba V. Evaluation of the association between gastric cancer and plasma selenium in Zambian adults: a case-control study. Ecancermedicalscience. 2022;16:1351.","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"4349_CR52","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0006-291X(03)00090-1","volume":"301","author":"M Fasshauer","year":"2003","unstructured":"Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2003;301(4):1045\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4349_CR53","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm724","volume":"8","author":"N Maeda","year":"2002","unstructured":"Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med. 2002;8(7):731\u20137.","journal-title":"Nat Med"},{"issue":"8","key":"4349_CR54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jcp.2009.066175","volume":"62","author":"V Barresi","year":"2009","unstructured":"Barresi V, Grosso M, Giuffr\u00e8 G, Tuccari G, Barresi G. The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol. 2009;62(8):705\u20139.","journal-title":"J Clin Pathol"},{"issue":"4","key":"4349_CR55","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3892\/ol.2014.1846","volume":"7","author":"H Yabushita","year":"2014","unstructured":"Yabushita H, Iwasaki K, Obayashi Y, Wakatsuki A. Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma. Oncol Lett. 2014;7(4):1109\u201317.","journal-title":"Oncol Lett"},{"issue":"3","key":"4349_CR56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18(3):283\u201393.","journal-title":"Mol Cell"},{"issue":"0","key":"4349_CR57","first-page":"33","volume":"9","author":"C Ming","year":"2023","unstructured":"Ming C, Orita H, Shangcheng Y, Yuan Q, Fedor CN, Yongyou W, et al. The role of adiponectin in gastric cancer. J Cancer Metastasis Treat. 2023;9(0):33.","journal-title":"J Cancer Metastasis Treat"},{"issue":"4","key":"4349_CR58","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/sj.bjc.6603579","volume":"96","author":"MA Forget","year":"2007","unstructured":"Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, Martin J, et al. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer. 2007;96(4):646\u201353.","journal-title":"Br J Cancer"},{"issue":"6665","key":"4349_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/34848","volume":"391","author":"A Glinka","year":"1998","unstructured":"Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391(6665):357\u201362.","journal-title":"Nature"},{"key":"4349_CR60","doi-asserted-by":"publisher","first-page":"658097","DOI":"10.3389\/fimmu.2021.658097","volume":"12","author":"HY Chu","year":"2021","unstructured":"Chu HY, Chen Z, Wang L, Zhang ZK, Tan X, Liu S, et al. Dickkopf-1: A promising target for cancer immunotherapy. Front Immunol. 2021;12:658097.","journal-title":"Front Immunol"},{"issue":"8","key":"4349_CR61","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.18632\/oncotarget.3464","volume":"6","author":"\u00d3 Aguilera","year":"2015","unstructured":"Aguilera \u00d3, Gonz\u00e1lez-Sancho JM, Zazo S, Rinc\u00f3n R, Fern\u00e1ndez AF, Tapia O, et al. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer. Oncotarget. 2015;6(8):5903\u201317.","journal-title":"Oncotarget"},{"issue":"5","key":"4349_CR62","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1182\/blood-2007-03-082529","volume":"110","author":"J Qian","year":"2007","unstructured":"Qian J, Xie J, Hong S, Yang J, Zhang L, Han X, et al. Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood. 2007;110(5):1587\u201394.","journal-title":"Blood"},{"issue":"12","key":"4349_CR63","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/2326-6066.CIR-22-0218","volume":"10","author":"T Shi","year":"2022","unstructured":"Shi T, Zhang Y, Wang Y, Song X, Wang H, Zhou X, et al. DKK1 promotes tumor immune evasion and impedes Anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer. Cancer Immunol Res. 2022;10(12):1506\u201324.","journal-title":"Cancer Immunol Res"},{"key":"4349_CR64","doi-asserted-by":"publisher","first-page":"103844","DOI":"10.1016\/j.amsu.2022.103844","volume":"78","author":"CL Nguyen","year":"2022","unstructured":"Nguyen CL, Dao TT, Phi T-TN, Nguyen TP, Pham VT, Vu TK. Serum pepsinogen: A potential non-invasive screening method for moderate and severe atrophic gastritis among an Asian population. Annals Med Surg. 2022;78:103844.","journal-title":"Annals Med Surg"},{"issue":"7","key":"4349_CR65","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.4251\/wjgo.v15.i7.1174","volume":"15","author":"Y Qin","year":"2023","unstructured":"Qin Y, Geng JX, Huang B. Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases. World J Gastrointest Oncol. 2023;15(7):1174\u201381.","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"4349_CR66","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/diagnostics12030695","volume":"12","author":"N Chapelle","year":"2022","unstructured":"Chapelle N, Osmola M, Martin J, Blin J, Leroy M, Jirka I, et al. Serum pepsinogens combined with new biomarkers testing using chemiluminescent enzyme immunoassay for Non-Invasive diagnosis of atrophic gastritis: A Prospective, multicenter study. Diagnostics. 2022;12(3):695.","journal-title":"Diagnostics"},{"issue":"6","key":"4349_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2169\/internalmedicine.46.6181","volume":"46","author":"C Mukoubayashi","year":"2007","unstructured":"Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, et al. Serum pepsinogen and gastric cancer screening. Intern Med. 2007;46(6):261\u20136.","journal-title":"Intern Med"},{"issue":"7","key":"4349_CR68","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1158\/1055-9965.EPI-21-1328","volume":"31","author":"H In","year":"2022","unstructured":"In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, et al. Serum pepsinogen as a biomarker for gastric cancer in the united states: A nested Case-Control study using the PLCO cancer screening trial data. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1426\u201332.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"4349_CR69","first-page":"186","volume":"54","author":"SS Wang","year":"2023","unstructured":"Wang SS, Guo ZP, Zhao XY. [Diagnostic value of serum pepsinogen \u2160\/Pepsinogen \u2161 combined with tumor markers for Helicobacter pylori-Positive Early-Stage gastric Cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54(1):186\u201391.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"4349_CR70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/sjg.sjg_383_22","volume":"29","author":"XK Lin","year":"2023","unstructured":"Lin XK, Wang WL. Analysis of high risk factors for chronic atrophic gastritis. Saudi J Gastroenterol. 2023;29(2):127\u201334.","journal-title":"Saudi J Gastroenterol"},{"issue":"5","key":"4349_CR71","first-page":"509","volume":"40","author":"MA Osundina","year":"2023","unstructured":"Osundina MA, Akere A, Akande KO, Oke TO, Otegbayo JA, Aje AO, et al. Usefulness of serum pepsinogen I as a biomarker in early diagnosis of aetiology of dyspepsia. West Afr J Med. 2023;40(5):509\u201318.","journal-title":"West Afr J Med"},{"issue":"1","key":"4349_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.34172\/mejdd.2023.318","volume":"15","author":"GR Sivandzadeh","year":"2023","unstructured":"Sivandzadeh GR, Zadeh Fard SA, Zahmatkesh A, Anbardar MH, Lankarani KB. Value of serological biomarker panel in diagnosis of atrophic gastritis and Helicobacter pylori infection. Middle East J Dig Dis. 2023;15(1):37\u201344.","journal-title":"Middle East J Dig Dis"},{"issue":"5","key":"4349_CR73","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/CEJ.0000000000000791","volume":"32","author":"E Ga\u0161enko","year":"2023","unstructured":"Ga\u0161enko E, Bogdanova I, Sjomina O, Aleksandravi\u010da I, Kir\u0161ners A, Anc\u0101ns G, et al. Assessing the utility of pepsinogens and gastrin-17 in gastric cancer detection. Eur J Cancer Prev. 2023;32(5):478\u201384.","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"4349_CR74","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1053\/j.gastro.2011.05.040","volume":"141","author":"S Aikou","year":"2011","unstructured":"Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011;141(3):837\u201345.e1-7.","journal-title":"Gastroenterology"},{"issue":"3","key":"4349_CR75","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.soi.2024.100086","volume":"1","author":"H In","year":"2024","unstructured":"In H, Adams A, Ho S, Sarkar S, Wang F, Oh A, et al. Pepsinogen and Helicobacter pylori: serum biomarkers for gastric cancer risk in a diverse united States population. Surg Oncol Insight. 2024;1(3):100086.","journal-title":"Surg Oncol Insight"},{"issue":"12","key":"4349_CR76","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1111\/jcmm.13258","volume":"21","author":"S Wu","year":"2017","unstructured":"Wu S, Yang L, Wu D, Gao Z, Li P, Huang W, et al. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression. J Cell Mol Med. 2017;21(12):3481\u201393.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4349_CR77","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.asjsur.2022.06.039","volume":"46","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang M, Wang Y, Cheng X, Jiang Y, Xiao H. Clinicopathologic significance of Her-2 and P53 expressions in gastric cancer. Asian J Surg. 2023;46(1):526\u201331.","journal-title":"Asian J Surg"},{"issue":"1","key":"4349_CR78","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1038\/s41598-018-20572-1","volume":"8","author":"J Ohtsuka","year":"2018","unstructured":"Ohtsuka J, Oshima H, Ezawa I, Abe R, Oshima M, Ohki R. Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers. Sci Rep. 2018;8(1):2291.","journal-title":"Sci Rep"},{"issue":"4","key":"4349_CR79","doi-asserted-by":"publisher","first-page":"813","DOI":"10.17305\/bb.2023.9937","volume":"24","author":"Z Misir","year":"2023","unstructured":"Misir Z, Glav\u010di\u0107 G, Jankovi\u0107 S, Kruljac I, \u010cugura Filipovi\u0107 J, \u010cimi\u0107 K, et al. The role of the NY-ESO-1 in the prognosis of gastric cancer. Biomol Biomed. 2023;24(4):813\u201320.","journal-title":"Biomol Biomed"},{"issue":"11","key":"4349_CR80","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.1007\/s00432-023-04732-z","volume":"149","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, He P, Zheng C, Chen Z, Qi S, Zhou D, et al. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion. J Cancer Res Clin Oncol. 2023;149(11):8369\u201378.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"4349_CR81","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ijc.27667","volume":"132","author":"P Zayakin","year":"2013","unstructured":"Zayakin P, Anc\u0101ns G, Sili\u0146a K, Meistere I, Kalni\u0146a Z, Andrejeva D, et al. Tumor-associated autoantibody signature for the early detection of gastric cancer. Int J Cancer. 2013;132(1):137\u201347.","journal-title":"Int J Cancer"},{"issue":"6","key":"4349_CR82","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jprot.2009.02.006","volume":"72","author":"G Kijanka","year":"2009","unstructured":"Kijanka G, Murphy D. Protein arrays as tools for serum autoantibody marker discovery in cancer. J Proteom. 2009;72(6):936\u201344.","journal-title":"J Proteom"},{"issue":"23","key":"4349_CR83","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1111\/j.1742-4658.2009.07396.x","volume":"276","author":"HT Tan","year":"2009","unstructured":"Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. Febs J. 2009;276(23):6880\u2013904.","journal-title":"Febs J"},{"key":"4349_CR84","doi-asserted-by":"publisher","unstructured":"Zhou C, Zhong X, Song Y, Shi J, Wu Z, Guo Z et al. Prognostic biomarkers for gastric cancer: an umbrella review of the evidence. Front Oncol. 2019;9:01321. https:\/\/doi.org\/10.3389\/fonc.2019.0132.","DOI":"10.3389\/fonc.2019.0132"},{"issue":"1","key":"4349_CR85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s43141-023-00539-0","volume":"21","author":"TG Selvan","year":"2023","unstructured":"Selvan TG, Gollapalli P, Kumar SHS, Ghate SD. Early diagnostic and prognostic biomarkers for gastric cancer: systems-level molecular basis of subsequent alterations in gastric mucosa from chronic atrophic gastritis to gastric cancer. J Genetic Eng Biotechnol. 2023;21(1):86.","journal-title":"J Genetic Eng Biotechnol"},{"key":"4349_CR86","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cca.2017.01.025","volume":"466","author":"S Chen","year":"2017","unstructured":"Chen S, Li T, Zhao Q, Xiao B, Guo J. Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer. Clin Chim Acta. 2017;466:167\u201371.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4349_CR87","doi-asserted-by":"publisher","first-page":"13119","DOI":"10.1038\/s41598-023-40132-6","volume":"13","author":"LV Mej\u00eda-Guarnizo","year":"2023","unstructured":"Mej\u00eda-Guarnizo LV, Monroy-Camacho PS, Rinc\u00f3n-Rodr\u00edguez DE, Rinc\u00f3n-Riveros A, Martinez-Vargas DA, Huertas-Caro CA, et al. Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer. Sci Rep. 2023;13(1):13119.","journal-title":"Sci Rep"},{"key":"4349_CR88","doi-asserted-by":"publisher","first-page":"101757","DOI":"10.1016\/j.tranon.2023.101757","volume":"37","author":"X Huang","year":"2023","unstructured":"Huang X, Xie X, Kang N, Qi R, Zhou X, Wang Y, et al. SERPINB5 is a novel serum diagnostic biomarker for gastric high-grade intraepithelial neoplasia and plays a role in regulation of macrophage phenotypes. Translational Oncol. 2023;37:101757.","journal-title":"Translational Oncol"},{"issue":"9","key":"4349_CR89","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.7150\/ijms.85180","volume":"20","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang Y, Li X, Li X, Gu X, Ju S. Serum tRF-27-FDXXE6XRK45 as a promising biomarker for the clinical diagnosis in gastric cancer. Int J Med Sci. 2023;20(9):1189\u2013201.","journal-title":"Int J Med Sci"},{"issue":"2","key":"4349_CR90","first-page":"190","volume":"19","author":"MA Shaqi","year":"2023","unstructured":"Shaqi MA, Rijub-Agha AKY, Hussain RJ. Serum pseudocholinesterase as a biomarker in the differentiation between gastric cancer and benign gastric diseases. AL-Kindy Coll Med J. 2023;19(2):190\u20135.","journal-title":"AL-Kindy Coll Med J"},{"issue":"8","key":"4349_CR91","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00042737-200608000-00004","volume":"18","author":"YK Tan","year":"2006","unstructured":"Tan YK, Fielding JWL. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006;18(8):821\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"14","key":"4349_CR92","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.3390\/jcm12144646","volume":"12","author":"Y Sato","year":"2023","unstructured":"Sato Y, Okamoto K, Kawano Y, Kasai A, Kawaguchi T, Sagawa T, et al. Novel biomarkers of gastric cancer: current research and future perspectives. J Clin Med. 2023;12(14):4646.","journal-title":"J Clin Med"},{"issue":"2","key":"4349_CR93","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12253-017-0251-1","volume":"24","author":"JY Yang","year":"2018","unstructured":"Yang JY, Li D, Zhang Y, Guan BX, Gao P, Zhou XC, et al. The expression of MCM7 is a useful biomarker in the early diagnostic of gastric cancer. Pathol Oncol Res. 2018;24(2):367\u201372.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"4349_CR94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15171\/jarcm.2018.029","volume":"6","author":"R Estakhri","year":"2018","unstructured":"Estakhri R, Masnadi Shirazi K, Ghojazadeh M, Ghazisoltani G, Azimpouran M, Fattahi S, et al. The diagnostic value of macrophage migration inhibitory factor, carcinoembryonic antigen, and carbohydrate antigen 19\u2009\u2013\u20099 in gastric cancer. J Anal Res Clin Med. 2018;6(4):179\u201385.","journal-title":"J Anal Res Clin Med"},{"issue":"22","key":"4349_CR95","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","volume":"339","author":"CK Osborne","year":"1998","unstructured":"Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339(22):1609\u201318.","journal-title":"N Engl J Med"},{"issue":"9","key":"4349_CR96","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1158\/1940-6207.CAPR-11-0219","volume":"4","author":"A Sheh","year":"2011","unstructured":"Sheh A, Ge Z, Parry NM, Muthupalani S, Rager JE, Raczynski AR, et al. 17\u03b2-estradiol and Tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. Cancer Prev Res (Phila). 2011;4(9):1426\u201335.","journal-title":"Cancer Prev Res (Phila)"},{"key":"4349_CR97","first-page":"1","volume":"61","author":"Schistosomes","year":"1994","unstructured":"Schistosomes. Liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1\u2013241.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"9","key":"4349_CR98","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrm1203","volume":"4","author":"D Taupin","year":"2003","unstructured":"Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4(9):721\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"4349_CR99","doi-asserted-by":"publisher","first-page":"9016","DOI":"10.1073\/pnas.0813362106","volume":"106","author":"G Yeretssian","year":"2009","unstructured":"Yeretssian G, Doiron K, Shao W, Leavitt BR, Hayden MR, Nicholson DW, et al. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci U S A. 2009;106(22):9016\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4349_CR100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00432-002-0336-3","volume":"128","author":"S Matsuyama","year":"2002","unstructured":"Matsuyama S, Ohkura Y, Eguchi H, Kobayashi Y, Akagi K, Uchida K, et al. Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol. 2002;128(6):319\u201324.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"4349_CR101","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0277-5379(83)90186-4","volume":"19","author":"A Tokunaga","year":"1983","unstructured":"Tokunaga A, Kojima N, Andoh T, Matsukura N, Yoshiyasu M, Tanaka N, et al. Hormone receptors in gastric cancer. Eur J Cancer Clin Oncol. 1983;19(5):687\u20139.","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"5","key":"4349_CR102","first-page":"3215","volume":"21","author":"M Pricci","year":"2001","unstructured":"Pricci M, Linsalata M, Russo F, Messa C, Amati L, Caradonna L, et al. Effects of 17beta-estradiol administration on apoptosis and polyamine content in AGS cell line. Anticancer Res. 2001;21(5):3215\u201320.","journal-title":"Anticancer Res"},{"issue":"3","key":"4349_CR103","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/1066896907302117","volume":"15","author":"YF Zhao","year":"2007","unstructured":"Zhao YF, Zhang YG, Tian XX, Juan D, Jie Z. Aberrant methylation of multiple genes in gastric carcinomas. Int J Surg Pathol. 2007;15(3):242\u201351.","journal-title":"Int J Surg Pathol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04349-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04349-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04349-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:05:05Z","timestamp":1760526305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04349-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04349-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences (ethics code: IR.TBZMED.VCR.REC.1402.213)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"737"}}